Literature DB >> 12171868

Renin-angiotensin-aldosterone activation in heart failure, aldosterone escape.

Philip Andrew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12171868     DOI： 10.1378/chest.122.2.755

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Hyponatremia: terminology and more.

Authors:  Philip Andrew
Journal:  CMAJ       Date:  2004-06-22       Impact factor: 8.262

2.  "Aldosterone escape" or refractory hyperaldosteronism?

Authors:  E Sankaranarayanan Prakash
Journal:  MedGenMed       Date:  2005-09-07

3.  Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure.

Authors:  Hailian Quan; Gyu Chul Oh; Seung Hyeok Seok; Hae-Young Lee
Journal:  Korean J Intern Med       Date:  2020-03-13       Impact factor: 2.884

4.  RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.

Authors:  Ibrahim F Benter; Fawzi Babiker; Ibrahim Al-Rashdan; Mariam Yousif; Saghir Akhtar
Journal:  J Diabetes Res       Date:  2013-08-27       Impact factor: 4.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.